To reduce the subjective symptoms and objective signs of cervical dystonia (spasmodic torticollis) in adults.
To reduce the subjective symptoms and objective signs of cervical dystonia (spasmodic torticollis) in adults.
To reduce the subjective symptoms and objective signs of cervical dystonia (spasmodic torticollis) in adults.
To reduce the subjective symptoms and objective signs of cervical dystonia (spasmodic torticollis) in adults.
For the management of focal spasticity, due to stroke or spinal cord injury in adults.
For the management of focal spasticity, due to stroke or spinal cord injury in adults.
For the treatment of blepharospasm associated with dystonia, including benign essential blepharospasm or VII nerve disorders in adults.
For the treatment of blepharospasm associated with dystonia, including benign essential blepharospasm or VII nerve disorders in adults. Xeomin should be administered personally by a neurologist or a physician with equivalent post-graduate training and experience with neuromuscular disorders.